,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny 04']
i excellent summary of the findings of destiny 04 by #asco22 quoting one of our patients from and 
Prof. & Chair Dept. of Heme and Oncology @ClevelandClinic @NRGonc Deputy Editor @JCOOP_ASCO Tweets are mine. No act of #Kindness is ever wasted #CleClinicCancer